Zobrazeno 1 - 10
of 523
pro vyhledávání: '"M. Schwager"'
Autor:
Juan M. Schwager, Nunzia Di Maggio, Andrea Grosso, Abeelan Rasadurai, Nadja Minder, Jeffrey A. Hubbell, Elisabeth A. Kappos, Dirk J. Schaefer, Priscilla S. Briquez, Andrea Banfi, Maximilian G. Burger
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
IntroductionThe stromal vascular fraction (SVF) of human adipose tissue is an attractive cell source for engineering grafts with intrinsic vascularization potential, as it is rich in vasculogenic progenitors. However, in order to maintain their funct
Externí odkaz:
https://doaj.org/article/4936bba93fb14ba699c358105dc3e122
Autor:
Paul J. Hampel, Kari G. Rabe, Timothy G. Call, Wei Ding, Jose F. Leis, Asher A. Chanan-Khan, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber B. Koehler, Ricardo Parrondo, Susan M. Schwager, Taimur Sher, Curtis A. Hanson, Min Shi, Daniel L. Van Dyke, Esteban Braggio, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-6 (2022)
Abstract Patients with chronic lymphocytic leukemia (CLL) with disease progression on ibrutinib have worse outcomes compared to patients stopping ibrutinib due to toxicity. A better understanding of expected outcomes in these patients is necessary to
Externí odkaz:
https://doaj.org/article/c5ee38417b3b4e7f8218d469cd1ba54f
Autor:
Rebecca L. King, Alia Gupta, Paul J. Kurtin, Wei Ding, Timothy G. Call, Kari G. Rabe, Saad S. Kenderian, Jose F. Leis, Yucai Wang, Susan M. Schwager, Susan L. Slager, Neil. E. Kay, Amber Koehler, Stephen M. Ansell, David J. Inwards, Thomas M. Habermann, Min Shi, Curtis A. Hanson, Matthew T. Howard, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract The distinction between chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) with isolated Hodgkin/Reed–Sternberg cells (CLL-HRS; background milieu with a paucity of inflammatory cells) and overt transformation to classic Hodg
Externí odkaz:
https://doaj.org/article/989c3e3359c44e3abd2c16b6d6766da6
Autor:
E. Y. Lukshina, V. V. Batashev, E. V. Kovalev, G. V. Karpushchenko, V. V. Balakhnova, N. V. Panasyuk, A. A. Alieva, V. V. Sidelnikov, M. M. Schwager, N. V. Polovinka, A. V. Polonsky, F. V. Logvin, N. G. Tutunkova, A. K. Noskov
Publikováno v:
Медицинский вестник Юга России, Vol 12, Iss 4, Pp 83-90 (2021)
Objective: To analyze the results of epizootic monitoring of natural foci of particularly dangerous infections common to humans and animals in Rostov Oblast to establish their activity.Materials and Methods: The data of epizootic monitoring conducted
Externí odkaz:
https://doaj.org/article/d99182e6c2084f23a1c451e41407e4b6
Autor:
Yucai Wang, Sara J. Achenbach, Kari G. Rabe, Tait D. Shanafelt, Timothy G. Call, Wei Ding, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Amber B. Koehler, Susan M. Schwager, James R. Cerhan, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 8, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/863bb1613c0f4313b4f20f6c1c59d34d
Autor:
Paul J. Hampel, Sameer A. Parikh, Timothy G. Call, Mithun V. Shah, N. Nora Bennani, Aref Al-Kali, Kari G. Rabe, Yucai Wang, Eli Muchtar, Jose F. Leis, Saad S. Kenderian, Amber B. Koehler, Susan M. Schwager, Susan L. Slager, Neil E. Kay, Curtis A. Hanson, Daniel L. Van Dyke, Min Shi, Wei Ding
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 3, Pp 1-6 (2021)
Externí odkaz:
https://doaj.org/article/5034355e2436472d9133161b489aabbc
Autor:
Sameer A. Parikh, Sara J. Achenbach, Timothy G. Call, Kari G. Rabe, Wei Ding, Jose F. Leis, Saad S. Kenderian, Asher A. Chanan‐Khan, Amber B. Koehler, Susan M. Schwager, Eli Muchtar, Amie L. Fonder, Kristen B. McCullough, Adrienne N. Nedved, Matthew D. Smith, Susan L. Slager, Neil E. Kay, Heidi D. Finnes, Tait D. Shanafelt
Publikováno v:
Cancer Medicine, Vol 9, Iss 10, Pp 3390-3399 (2020)
Abstract To study the impact of dose modification and temporary interruption of ibrutinib in routine clinical practice, we conducted a retrospective study of consecutive CLL patients treated with ibrutinib outside the context of a clinical trial at M
Externí odkaz:
https://doaj.org/article/ec5898c07904452d8346728e1b2de5a5
Autor:
Yucai Wang, Marcella A. Tschautscher, Kari G. Rabe, Timothy G. Call, Jose F. Leis, Saad S. Kenderian, Neil E. Kay, Eli Muchtar, Daniel L. Van Dyke, Amber B. Koehler, Susan M. Schwager, Susan L. Slager, Sameer A. Parikh, Wei Ding
Publikováno v:
Haematologica, Vol 105, Iss 3 (2020)
The natural history, prognostication and optimal treatment of Richter transformation developed from chronic lymphocytic leukemia (CLL) are not well defined. We report the clinical characteristics and outcomes of a large series of biopsy-confirmed Ric
Externí odkaz:
https://doaj.org/article/0a28ead1701247398d3622a34a0b481c
Autor:
Yucai Wang, Kari G. Rabe, Michael S. Bold, Min Shi, Curtis A. Hanson, Susan M. Schwager, Timothy G. Call, Saad S. Kenderian, Eli Muchtar, Suzanne R. Hayman, Amber B. Koehler, Amie L. Fonder, Asher A. Chanan-Khan, Daniel L. Van Dyke, Susan L. Slager, Neil E. Kay, Wei Ding, Jose F. Leis, Sameer A. Parikh
Publikováno v:
Haematologica, Vol 105, Iss 11 (2020)
Externí odkaz:
https://doaj.org/article/583604c4d80b473c848de91a69758bf4
Autor:
E. V. Kovalev, G. V. Karpushchenko, M. M. Schwager, A. V. Polonsky, V. V. Sidelnikov, A. Yu. Goncharov, N. V. Polovinka
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 16, Iss 6, Pp 37-40 (2017)
Since 1933 in the Rostov region, the official registration of tularemia began. In 1964-1949 the highest incidence was noted. Since 1947, they have been vaccinated against tularemia. In 1966 to 1973, there were no cases of tularemia. In July-August 19
Externí odkaz:
https://doaj.org/article/568740724e864aef837e3135c1b6c9bf